Idexx Laboratories (IDXX) Debt to Equity (2009 - 2026)

Idexx Laboratories (IDXX) has reported Debt to Equity for 18 consecutive years, with $0.53 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt to Equity rose 24.4% year-over-year to $0.53; the TTM figure through Mar 2026 stood at $0.53 (up 24.4% YoY), while the FY2025 annual figure was $0.28, down 36.12% from the prior year.
• Debt to Equity came in at $0.53 for Q1 2026 at Idexx Laboratories, up from $0.28 in the prior quarter.
• The five-year high for Debt to Equity was $3.02 in Q2 2022, with the low at $0.28 in Q4 2025.
• Average Debt to Equity over 5 years is $0.94, with a median of $0.56 recorded in 2024.
• Across the five-year window, Debt to Equity soared 159.33% in 2022 and tumbled 79.76% in 2023, its largest moves.
• Year by year, Debt to Equity stood at $1.55 in 2022, then tumbled by 69.7% to $0.47 in 2023, then declined by 6.69% to $0.44 in 2024, then plunged by 36.12% to $0.28 in 2025, then soared by 90.32% to $0.53 in 2026.
• According to Business Quant data, Debt to Equity over the past three periods registered $0.53, $0.28, and $0.53 for Q1 2026, Q4 2025, and Q3 2025 respectively.